US clinical-stage biotherapeutics company, Seaport Therapeutics’ investigational allopregnanolone prodrug, SPT-300, has been ...

Boston-based Seaport said the money would support a pipeline of improved neuropsychiatric drug candidates led by SPT-300, an oral prodrug of allopregnanolone that is being studied for major ...